143 related articles for article (PubMed ID: 10913345)
1. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
[TBL] [Abstract][Full Text] [Related]
2. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
3. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
4. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
Bouras T; Frauman AG
J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
[TBL] [Abstract][Full Text] [Related]
5. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
6. Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.
Duriez C; Falette N; Cortes U; Moyret-Lalle C; Puisieux A
Oncogene; 2000 May; 19(20):2461-4. PubMed ID: 10828889
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
8. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
9. Is the KAI1 metastasis suppressor gene a cellular target of p53? A review of current evidence.
Jackson P; Puisieux A
Biochem Biophys Res Commun; 2000 Nov; 278(3):499-502. PubMed ID: 11095940
[No Abstract] [Full Text] [Related]
10. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
[TBL] [Abstract][Full Text] [Related]
11. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization of the human KAI1 metastasis-suppressor gene.
Dong JT; Isaacs WB; Barrett JC; Isaacs JT
Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
[TBL] [Abstract][Full Text] [Related]
13. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
Yang X; Wei LL; Tang C; Slack R; Mueller S; Lippman ME
Cancer Res; 2001 Jul; 61(13):5284-8. PubMed ID: 11431371
[TBL] [Abstract][Full Text] [Related]
15. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
[TBL] [Abstract][Full Text] [Related]
16. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene.
Gao AC; Lou W; Dong JT; Barrett JC; Danielpour D; Isaacs JT
Prostate; 2003 Dec; 57(4):256-60. PubMed ID: 14601021
[TBL] [Abstract][Full Text] [Related]
17. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
19. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]